Skip to main content

Therapy and clinical trials.

Publication ,  Journal Article
Devendra, GP; Krasuski, RA
Published in: Curr Opin Lipidol
October 2010

Duke Scholars

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

October 2010

Volume

21

Issue

5

Start / End Page

471 / 472

Location

England

Related Subject Headings

  • Risk
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Diabetes Complications
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Devendra, G. P., & Krasuski, R. A. (2010). Therapy and clinical trials. Curr Opin Lipidol, 21(5), 471–472. https://doi.org/10.1097/MOL.0b013e32833e4f13
Devendra, Ganesh P., and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol 21, no. 5 (October 2010): 471–72. https://doi.org/10.1097/MOL.0b013e32833e4f13.
Devendra GP, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2010 Oct;21(5):471–2.
Devendra, Ganesh P., and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol, vol. 21, no. 5, Oct. 2010, pp. 471–72. Pubmed, doi:10.1097/MOL.0b013e32833e4f13.
Devendra GP, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2010 Oct;21(5):471–472.

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

October 2010

Volume

21

Issue

5

Start / End Page

471 / 472

Location

England

Related Subject Headings

  • Risk
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Diabetes Complications
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences